InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: Paulness post# 1336

Monday, 10/16/2017 9:02:49 AM

Monday, October 16, 2017 9:02:49 AM

Post# of 2794
Their presenting of Lomab-B for the treatment of bone marrow cancer is going to be very interesting. They are presenting their presentation @ 3 pm tomorrow. Actinium has develop a different way of treating bone marrow cancer with out the large invasive of the use of chemo, which in giving thru out the whole body, while Lomab-B therapy treatment only attack the cancerous cells of the bone marrow.

I would like to here from the clinical trial management team talk about the results and updated on Lomab-B new data tomorrow. keeping ATNM on my watch list.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News